The CRISPR AgBio industry approached a key turning point. Numerous product concepts awaited approval from the USDA, the European Union considered loosening regulatory constraints, and partnerships expanded.

The 7th CRISPR AgBio Congress provided a timely opportunity to explore the latest breakthroughs and emerging trends driving the future of agricultural biotechnology. With key regulatory decisions on the horizon and new collaborations reshaping the landscape, the conference equipped attendees with actionable insights to accelerate innovation and navigate evolving regulatory frameworks. Participants gained access to cutting-edge developments in gene editing, crop trait advancements, and delivery systems.

A diverse community of research pioneers, trait discovery specialists, delivery system experts, regulatory authorities, innovation scouts, and product strategists from biotech companies, seed industry leaders, growers, food producers, academia, and government agencies came together to advance gene-edited and modified products towards market readiness for 2025 and beyond.